Mary Sano, PhD
img_Mary Sano
ASSOCIATE DEAN FOR CLINICAL RESEARCH
PROFESSOR | Psychiatry
Are you a patient?
Specialties
Psychology

Internship, Clinical Neuropsychology, Columbia University Irving Medical Center

Publications

Selected Publications

evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease. Jeffrey L. Cummings, Alireza Atri, Howard H. Feldman, Oskar Hansson, Mary Sano, Filip K. Knop, Peter Johannsen, Teresa León, Philip Scheltens. Alzheimer's Research and Therapy

Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer’s disease. Farid Rajabli, Penelope Benchek, Giuseppe Tosto, Nicholas Kushch, Jin Sha, Katrina Bazemore, Congcong Zhu, Wan Ping Lee, Jacob Haut, Kara L. Hamilton-Nelson, Nicholas R. Wheeler, Yi Zhao, John J. Farrell, Michelle A. Grunin, Yuk Yee Leung, Pavel P. Kuksa, Donghe Li, Eder Lucio da Fonseca, Jesse B. Mez, Ellen L. Palmer, Jagan Pillai, Richard M. Sherva, Yeunjoo E. Song, Xiaoling Zhang, Takeshi Ikeuchi, Taha Iqbal, Omkar Pathak, Otto Valladares, Dolly Reyes-Dumeyer, Amanda B. Kuzma, Erin Abner, Larry D. Adams, Perrie M. Adams, Alyssa Aguirre, Marilyn S. Albert, Roger L. Albin, Mariet Allen, Lisa Alvarez, Liana G. Apostolova, Steven E. Arnold, Sanjay Asthana, Craig S. Atwood, Sanford Auerbach, Gayle Ayres, Clinton T. Baldwin, Robert C. Barber, Joseph D. Buxbaum, Brian Fulton-Howard, Alison M. Goate, Mary Sano. Genome Biology

Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer’s disease. Yuqi Qiu, Diane M. Jacobs, Karen Messer, David P. Salmon, Cheryl L. Wellington, Sophie Stukas, Carolyn Revta, James B. Brewer, Gabriel C. Léger, Brianna Askew, Lia Donahue, Stephen Kaplita, Vladimir Coric, Irfan A. Qureshi, Howard H. Feldman, Mark Brody, Jeffrey Ross, Anna Burke, Sudha Seshadri, Cherian Verghese, Stephen Flitman, Peter McCallister, Richard Shubin, Alexander Beyzer, James J. Peters, Mary Sano, Maya Lichtenstein, Clifford Singer, David Weisman, Kiran Bath, Olga Tchikindas, Sharon Brangman, Christos Sidiropoulos, Andrea Bozoki, Jeffrey Keller, Bernard Baumel, Olga Brawman-Mintzer, Jacobo Mintzer, Michael Karathanos, Ralph Richter, Charles Bernick, Aaron Ritter, Jonathan Drake, Elaine Peskind, Del D. Miller, Douglas Scharre, Alan Lerner, Alireza Atri, Bryan Spann, Alan Siegal. Alzheimer's Research and Therapy

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Sano during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Bristol-Meyers Company
  • Novo Nordisk, Inc.
  • Synaptic Development
  • Signant Health
  • Cervomed

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.